1 Global Maternal Health Market Size (Value) and CAGR (2024-2033)
In 2024, the global Maternal Health market was valued at USD 30271.6 million, with a CAGR of 5.5% from 2024 to 2033.
Maternal health refers to the health of women during pregnancy, childbirth and the postpartum period. It encompasses the health care dimensions of family planning, preconception, prenatal, and postnatal care in order to ensure a positive and fulfilling experience, in most cases, and reduce maternal morbidity and mortality, in other cases. The major causes of maternal morbidity and mortality include haemorrhage, infection, high blood pressure, unsafe abortion, and obstructed labour.
Figure Global Maternal Health Market Size (M USD) and CAGR 2024-2033
2 Maternal Health Market Drivers
One of the primary drivers of the Maternal Health market is the growing awareness of the critical role micronutrients play during pregnancy. Pregnant women require essential vitamins and minerals such as iron, iodine, vitamin A, and folic acid to support fetal development and maintain their own health. Deficiencies in these micronutrients can lead to severe complications, including anemia, premature birth, and low birth weight. As a result, there has been a surge in demand for prenatal vitamins, supplements, and fortified foods designed to meet the nutritional needs of expectant mothers. This increased awareness is particularly evident in developing countries, where micronutrient deficiencies are more prevalent.
The global rise in women’s social, economic, and political status has had a profound impact on the Maternal Health market. Higher levels of education and economic independence have empowered women to take greater control of their health and well-being. Additionally, increased female representation in government has led to policies that prioritize maternal health, resulting in better access to healthcare services and resources. For example, studies have shown that a 1% increase in women’s representation in government corresponds to a significant reduction in maternal mortality rates. This trend is further supported by international initiatives such as the United Nations’ Sustainable Development Goals, which aim to reduce maternal mortality and promote gender equality.
Advancements in healthcare technology and medical research have significantly improved maternal health outcomes. Innovations in prenatal diagnostics, neonatal care, and telemedicine have made it easier for healthcare providers to monitor and manage pregnancies, reducing the risk of complications. Additionally, the development of new pharmaceuticals and medical devices has enhanced the treatment options available for expectant mothers. For instance, the use of information and communication technology (ICT) has enabled remote consultations, health reminders, and emergency referrals, making healthcare more accessible and efficient.
3 Maternal Health Market PEST Analysis
Political will and policy-making have a significant impact on the Maternal Health market. Governments around the world are increasingly prioritizing maternal health as part of their public health agendas. This shift is driven by the recognition that maternal mortality and morbidity rates are key indicators of a country’s overall health status. As a result, many countries have implemented policies aimed at improving access to prenatal care, reducing maternal mortality, and promoting gender equality. For example, the Sustainable Development Goals (SDGs) set by the United Nations include specific targets for reducing maternal mortality and increasing women’s representation in government.
Economic conditions play a crucial role in shaping the Maternal Health market. In developed countries, higher disposable incomes and access to quality healthcare services have led to increased demand for premium maternal health products and services. However, in low- and middle-income countries, economic constraints such as poverty, limited healthcare infrastructure, and high out-of-pocket costs remain significant barriers to accessing maternal health care.
Social and cultural factors also influence the Maternal Health market. The rise in women’s social status and education levels has led to greater awareness and demand for maternal health services. Additionally, the increasing prevalence of social media and digital platforms has facilitated the dissemination of information on maternal health, empowering women to make informed decisions about their healthcare.
Technological advancements have revolutionized the Maternal Health market, making healthcare more accessible and efficient. Innovations in prenatal diagnostics, neonatal care, and telemedicine have significantly improved maternal health outcomes. For example, the use of mobile health applications and remote monitoring devices allows healthcare providers to better manage pregnancies and detect potential complications early.
4 Global Maternal Health Market Size and Share by Type in 2024
Hormones are essential biological substances that regulate various physiological processes during pregnancy. They play a crucial role in maintaining pregnancy, fetal development, and preparing the body for childbirth. Common hormones used in maternal health include progesterone, estrogen, and thyroid hormones. In 2024, the Hormones segment is projected to reach $79.0 million. This segment is driven by the increasing demand for hormone replacement therapies and supplements to manage conditions such as hypothyroidism and progesterone deficiency during pregnancy.
Nutritives represent the largest segment of the Maternal Health market, with a projected value of $28,339.0 million in 2024. These products are designed to provide essential nutrients to pregnant women, including vitamins, minerals, and other dietary supplements that support fetal growth and maternal health. Examples include folic acid, iron, calcium, and omega-3 fatty acids. Nutritional deficiencies during pregnancy can have severe consequences for both the mother and the fetus, making this segment critical. The growth of Nutritives is driven by increasing awareness of the importance of prenatal nutrition and the rising demand for high-quality supplements to prevent deficiencies and support healthy pregnancies.
Analgesics are medications used to relieve pain during pregnancy and childbirth. These products are essential for managing labor pain and postpartum discomfort. Common analgesics include acetaminophen, ibuprofen, and opioids for severe pain. In 2024, the Analgesics segment is projected to reach $578.7 million. The demand for analgesics is driven by the increasing number of childbirths and the need for effective pain management solutions. Advances in pain management technologies and the availability of safer analgesics are expected to drive the growth of this segment.
Table Global Maternal Health Market Size and Share by Type in 2024
Type | Market Size (M USD) 2024 | Market Share 2024 |
Hormones | 79.0 | 0.26% |
Nutritives | 28339.0 | 93.62% |
Analgesics | 578.7 | 1.91% |
Anti-Infectives | 205.4 | 0.68% |
Others | 1069.5 | 3.53% |
5 Global Maternal Health Market Size and Share by Application in 2024
Hospitals are critical centers for maternal care, providing comprehensive services ranging from prenatal check-ups to childbirth and postpartum care. In 2024, the market value for Maternal Health products and services in hospitals is projected to reach $5,348.9 million. This segment is driven by the increasing number of hospital deliveries and the need for advanced medical care to manage complications during pregnancy and childbirth. Hospitals are also at the forefront of implementing new technologies and treatments to improve maternal health outcomes.
Clinics play a significant role in providing accessible maternal health services, especially in rural and underserved areas. The market value for Maternal Health products and services in clinics is projected to reach $3,762.1 million in 2024. Clinics offer a range of services, including prenatal consultations, vaccinations, and basic diagnostic tests. The growth of this segment is driven by the increasing demand for affordable and accessible healthcare services, as well as the expansion of community-based healthcare initiatives.
Household represents the largest application segment, with a projected market value of $21,160.7 million in 2024. This segment includes over-the-counter supplements, vitamins, and home care products designed for pregnant women. The growth of this segment is driven by increasing consumer awareness of the importance of prenatal nutrition and the rising demand for convenient, at-home solutions. Products such as prenatal vitamins, omega-3 supplements, and home pregnancy tests are particularly popular in this category.
Table Global Maternal Health Market Size and Share by Application in 2024
Application | Market Size (M USD) 2024 | Market Share 2024 |
Hospitals | 5348.9 | 17.67% |
Clinics | 3762.1 | 12.43% |
Household | 21160.7 | 69.90% |
6 Global Maternal Health Market Size by Region in 2024
North America is a leading region in the Maternal Health market, with a projected value of $6,773.4 million in 2024. This region is characterized by high awareness of maternal health issues, advanced healthcare infrastructure, and a strong focus on preventive care. The growth of this segment is driven by increasing demand for high-quality maternal health products and services, as well as the presence of major healthcare companies and research institutions.
Europe is another significant region, with a projected market value of $5,299.9 million in 2024. European countries are known for their robust healthcare systems and strong emphasis on maternal and child health. The growth of the Maternal Health market in Europe is driven by government initiatives to improve maternal health outcomes, as well as the increasing adoption of advanced diagnostic tools and treatments.
Asia-Pacific is the fastest-growing region in the Maternal Health market, with a projected value of $14,901.1 million in 2024. This region includes countries such as China, India, and Japan, which are experiencing rapid economic growth and increasing demand for maternal health products and services. The growth of this segment is driven by rising awareness of maternal health issues, increasing healthcare spending, and the expansion of healthcare infrastructure in emerging economies.
Figure Global Maternal Health Market Share by Region in 2024
7 Major Players in Global Maternal Health Market
7.1 Bayer AG
Company Profile:
Bayer AG is a global healthcare and life sciences company founded in 1863 and headquartered in Germany. With a long history of innovation, Bayer is known for its wide range of products, including pharmaceuticals, consumer health products, and agricultural solutions. The company’s commitment to improving health and well-being aligns closely with its maternal health offerings.
Business Overview:
Bayer AG operates in multiple sectors, including pharmaceuticals, consumer health, and crop science. Its maternal health products are part of the consumer health division, which focuses on providing essential vitamins, minerals, and supplements to support women’s health during pregnancy and breastfeeding. Bayer’s maternal health products are designed to meet the specific nutritional needs of expectant and new mothers, ensuring a healthy pregnancy and postpartum period.
Product and Service Analysis:
Bayer’s maternal health offerings include Elevit Pre-conception & Pregnancy Multivitamin, a comprehensive supplement formulated with 19 vitamins and minerals to support the nutritional needs of women during pregnancy and breastfeeding. This product is marketed globally and is highly regarded for its effectiveness in preventing deficiencies and supporting overall maternal health.
Recent Financial Performance:
In the most recent year, Bayer AG’s maternal health segment reported a market value of $334.9 million with a gross margin of 66.90%.
7.2 BY-Health Co Ltd
Company Profile:
BY-Health Co Ltd, established in 1995 and headquartered in China, is a leading provider of dietary supplements and functional foods. The company focuses on delivering high-quality health products that address various health needs, including those specific to maternal health. BY-Health’s commitment to innovation and quality has positioned it as a key player in the global maternal health market.
Business Overview:
BY-Health operates in the health supplement industry, offering a wide range of products such as protein powders, vitamins, minerals, and herbal extracts. Its maternal health products are designed to support the nutritional needs of pregnant women, ensuring optimal health for both mother and baby. BY-Health’s global distribution network allows it to reach a wide audience, further enhancing its market presence.
Product and Service Analysis:
BY-Health’s maternal health offerings include the Multi-vitamin & Mineral Tablet for Early Pregnancy, which provides essential nutrients to support the health of pregnant women. This product is formulated with key ingredients such as folic acid, iron, and calcium, which are crucial for preventing deficiencies and supporting fetal development.
Recent Financial Performance:
In the most recent year, BY-Health Co Ltd’s maternal health segment reported a market value of $251.7 million with a gross margin of 68.27%.
7.3 The Bountiful Company
Company Profile:
The Bountiful Company, founded in 1971 and headquartered in the United States, is a leading health and wellness company. The company is known for its high-quality vitamins, minerals, herbal supplements, and protein products. The Bountiful Company’s commitment to health and wellness aligns closely with its maternal health offerings, which aim to support the nutritional needs of pregnant women and new mothers.
Business Overview:
The Bountiful Company operates in the health and wellness sector, offering a wide range of products designed to support overall health and well-being. Its maternal health products focus on providing essential nutrients to support the health of pregnant women and their babies. The company’s global presence and strong brand recognition have contributed to its success in the maternal health market.
Product and Service Analysis:
The Bountiful Company’s maternal health offerings include Essential Prenatal Gummies, which provide essential nutrients such as folic acid, iodine, and omega-3 fatty acids. These products are designed to meet the specific nutritional needs of pregnant women, ensuring a healthy pregnancy and postpartum period. The company’s commitment to quality and innovation has positioned it as a trusted provider of maternal health products.
Recent Financial Performance:
In the most recent year, The Bountiful Company’s maternal health segment reported a market value of $188.7 million with a gross margin of 67.42%.